1. Home
  2. ARCT vs ESQ Comparison

ARCT vs ESQ Comparison

Compare ARCT & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • ESQ
  • Stock Information
  • Founded
  • ARCT 2013
  • ESQ 2006
  • Country
  • ARCT United States
  • ESQ United States
  • Employees
  • ARCT N/A
  • ESQ N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • ESQ Commercial Banks
  • Sector
  • ARCT Health Care
  • ESQ Finance
  • Exchange
  • ARCT Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • ARCT 320.8M
  • ESQ 838.1M
  • IPO Year
  • ARCT N/A
  • ESQ 2017
  • Fundamental
  • Price
  • ARCT $17.32
  • ESQ $97.03
  • Analyst Decision
  • ARCT Strong Buy
  • ESQ Hold
  • Analyst Count
  • ARCT 10
  • ESQ 3
  • Target Price
  • ARCT $50.88
  • ESQ $103.00
  • AVG Volume (30 Days)
  • ARCT 536.4K
  • ESQ 53.9K
  • Earning Date
  • ARCT 11-06-2025
  • ESQ 10-23-2025
  • Dividend Yield
  • ARCT N/A
  • ESQ 0.72%
  • EPS Growth
  • ARCT N/A
  • ESQ 12.45
  • EPS
  • ARCT N/A
  • ESQ 5.39
  • Revenue
  • ARCT $122,122,000.00
  • ESQ $126,841,000.00
  • Revenue This Year
  • ARCT N/A
  • ESQ N/A
  • Revenue Next Year
  • ARCT $31.09
  • ESQ $27.16
  • P/E Ratio
  • ARCT N/A
  • ESQ $18.10
  • Revenue Growth
  • ARCT N/A
  • ESQ 12.91
  • 52 Week Low
  • ARCT $8.04
  • ESQ $59.95
  • 52 Week High
  • ARCT $25.88
  • ESQ $106.11
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 54.49
  • ESQ 49.01
  • Support Level
  • ARCT $17.38
  • ESQ $92.33
  • Resistance Level
  • ARCT $18.69
  • ESQ $98.88
  • Average True Range (ATR)
  • ARCT 1.00
  • ESQ 2.21
  • MACD
  • ARCT -0.11
  • ESQ -0.14
  • Stochastic Oscillator
  • ARCT 44.23
  • ESQ 49.84

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: